PCRX
NASDAQ · Pharmaceuticals
Pacira Biosciences Inc
$36.43
+0.01 (+0.03%)
Open$36.42
Previous Close$36.42
Day High$36.45
Day Low$36.42
52W High$36.67
52W Low$18.80
Volume—
Avg Volume936.0K
Market Cap1.45B
P/E Ratio99.22
EPS$0.35
SectorPharmaceuticals
Analyst Ratings
Buy
15 analysts
Price Target
-37.7% upside
Current
$36.43
$36.43
Target
$22.71
$22.71
$15.64
$22.71 avg
$35.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 643.49M | 625.35M | 216.59M |
| Net Income | 6.23M | 5.45M | 41.33M |
| Profit Margin | 1.0% | 0.9% | 19.1% |
| EBITDA | 57.13M | 52.75M | 75.27M |
| Free Cash Flow | — | — | 28.35M |
| Rev Growth | +2.9% | +2.9% | +14.7% |
| Debt/Equity | 0.54 | 0.54 | 0.92 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |